WALKER LUKE NATHANIEL purchased 19.6% of their position (14.20K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $25.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2025ACC: 0001725160-25-000029
Director
Since May 2024
+14.20K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.20K
Price / share
$1.76
Trade value
$24.97K
% of position
19.6%
1/31/2025
72.48K→86.68K
Total
Net shares
+14.20K
Net value
$24.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | P · Purchase | +14.20K | $1.76 | $24.97K | 19.6% | 72.48K | 86.68K |
| Total | +14.20K | $24.97K | ||||||
Derivative Transactions0
No derivative transactions reported